Creative Medical Technology Holdings, Inc. Total Long-Term Debt
Creative Medical Technology Holdings, Inc. (CELZ) had Total Long-Term Debt of $5.15 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2021-11-15
- 2021-09-30: Long-term Debt $5.15M.
- 2021-06-30: Long-term Debt $342.45K.
- 2021-03-31: Long-term Debt $662.79K.
- 2020-09-30: Long-term Debt $1.20M.
| Period end | Long-term Debt |
|---|---|
| 2021-09-30 | $5.15M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $342.45K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $662.79K 10-Q · filed 2021-05-17 |
| 2020-09-30 | $1.20M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.38M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.47M 10-Q · filed 2020-05-15 |
| 2019-09-30 | $1.53M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.65M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.99M 10-Q · filed 2019-05-20 |
| 2018-09-30 | $987.75K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $673.09K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $756.81K 10-Q · filed 2018-08-03 |
| 2017-12-31 | $493.25K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |